NCT02183467View on ClinicalTrials.gov

Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Conditions
Healthy
Interventions
DRUG

BI 1356, low dose

DRUG

BI 1356, high dose

DRUG

Placebo

DRUG

Moxifloxacin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183467 - Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects | Biotech Hunter | Biotech Hunter